New eye injection aims to halt blinding disease in older adults
Disease control
Recruiting now
This study tests an experimental eye injection called ONL1204 in 324 adults aged 55 and older with geographic atrophy, a severe form of dry age-related macular degeneration that causes blind spots. The goal is to see if the drug can slow the growth of damaged areas in the retina …
Phase: PHASE2 • Sponsor: ONL Therapeutics • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC